NOTCH3 and non-small cell lung carcinoma: Results showed that EVO up-regulated the DNMT3A protein level in NSCLC cells, and it also increased the protein level of DNMT3B in H1299 cells (Figure 5C), suggesting that activation of the DNMTs-induced NOTCH3 methylation may be one of the mechanisms for EVO’s anti-NSCLC effects.